Colombi Irene, Ginetti Alessandro, Cannoni Alberto, Cimino Giulia, d'Abate Claudia, Schettini Giorgia, Giorgi Matteo, Raimondo Diego, Martire Francesco Giuseppe, Lazzeri Lucia, Zupi Errico, Centini Gabriele
Department of Molecular and Developmental Medicine, Obstetrics and Gynecological Clinic University of Siena, 51300 Siena, Italy.
Obstetrics and Gynecology Unit, Valdarno Hospital, 52025 Montevarchi, Arezzo, Italy.
J Clin Med. 2024 Dec 2;13(23):7349. doi: 10.3390/jcm13237349.
Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by the presence of endometrial tissue outside the uterus, causing pelvic pain and infertility. Infertility arises mainly due to inflammatory mediators in the peritoneal fluid, contributing to local hypoestrogenism, which appears to exacerbate chronic inflammation and sensitize pelvic nerves. Local hypoestrogenism within endometriotic lesions contrasts with the systemic estrogen-dependent nature of the disease. This localized reduction in estrogen levels, resulting from an altered hormonal response, can contribute to the altered immune response and inflammation characteristic of endometriosis, potentially exacerbating tissue damage, promoting fibrosis, adhesions, and endometrioma formation that distort pelvic anatomy, and affecting fertility. Chronic pelvic pain and dyspareunia further complicate conception in affected women. In vitro fertilization (IVF) and laparoscopic surgical excision of endometriotic lesions are the two primary management options for endometriosis-related infertility, although current data provide limited guidance on when to prefer one approach over the other. It is generally accepted that treatment strategies must be individualized according to the patient's wishes, symptomatology, age and the preferences of the woman and the couple. Timely intervention and structured follow-up for symptomatic women wishing to conceive may maximize conception rates within two years post-surgery, while minimizing the need for repeated interventions, which should be avoided. On the other hand, first-line IVF is particularly viable in cases of unoperated deep infiltrating endometriosis in asymptomatic women, or for those ineligible for or opposed to surgery. This review aims to evaluate the most recent data on endometriosis-related infertility to identify evidence-based key points that can enhance tailored management in clinical practice.
子宫内膜异位症是一种慢性、雌激素依赖性炎症性疾病,其特征是子宫外存在子宫内膜组织,可导致盆腔疼痛和不孕。不孕主要是由于腹腔液中的炎症介质所致,这些介质会导致局部雌激素水平降低,这似乎会加剧慢性炎症并使盆腔神经敏感化。子宫内膜异位症病灶内的局部雌激素水平降低与该疾病的全身性雌激素依赖性本质形成对比。这种因激素反应改变导致的雌激素水平局部降低,可能会导致子宫内膜异位症特有的免疫反应和炎症改变,从而可能加剧组织损伤、促进纤维化、粘连和子宫内膜瘤形成,进而扭曲盆腔解剖结构并影响生育能力。慢性盆腔疼痛和性交困难会使受影响女性的受孕更加复杂。体外受精(IVF)和腹腔镜手术切除子宫内膜异位症病灶是治疗子宫内膜异位症相关不孕的两种主要方法,尽管目前的数据对于何时优先选择一种方法而非另一种方法提供的指导有限。人们普遍认为,治疗策略必须根据患者的意愿、症状、年龄以及女性和夫妇双方的偏好进行个体化制定。对于希望受孕的有症状女性,及时干预和结构化随访可在术后两年内使受孕率最大化,同时尽量减少重复干预的必要性,应避免重复干预。另一方面,一线IVF在无症状女性未手术的深部浸润性子宫内膜异位症病例中,或对于那些不适合手术或反对手术的女性中尤其可行。本综述旨在评估关于子宫内膜异位症相关不孕的最新数据,以确定可在临床实践中加强个体化管理的循证关键点。